Oxford Biomedica OXB
There have not been any declared dividends recently.
|Summary||Previous dividend||Next dividend|
Enter the number of Oxford Biomedica shares you hold and we'll calculate your dividend payments:
Sign up for Oxford Biomedica and we'll email you the dividend information when they declare.
Add Oxford Biomedica to receive free notifications when they declare their dividends.
Your account is set up to receive Oxford Biomedica notifications.
|Status||Type||Decl. date||Ex-div date||Pay date||Decl. Currency||Forecast amount||Decl. amount||Accuracy|
|There are no Oxford Biomedica dividends.|
|2021||Sign Up Required|
Oxford Biomedica Optimized Dividend Chart
About Oxford Biomedica
Oxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company's segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners. The R&D segment is engaged in the development of in-vivo and ex-vivo gene and cell therapy products, and the development of lentivirus-related platform technology. The Company provides a platform of technologies and capabilities with which it designs, develops and produces gene and cell-based medicines. The Company's product pipeline of OXB-102, OXB-201, OXB-202 and OXB-302 addresses neurodegenerative and ocular diseases, and a range of cancers. OXB-102 is indicated for Parkinson's disease. OXB-202 is indicated for Ocular (corneal graft rejection). OXB-302 is indicated for cancer disease. Its OXB-201 is indicated for wet age-related macular degeneration.